Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
bms-690514 epidermal growth factor receptor NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic pain[MeSHID:D059350]		 0.36 phase 2 inhibitor
bms-690514 epidermal growth factor receptor NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic pain[MeSHID:D059350]		 0.36 phase 2 unknown
bms-690514 erbb2 messenger rna NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic pain[MeSHID:D059350]		 0.37 phase 2 unknown
bms-690514 erbb2 messenger rna NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic pain[MeSHID:D059350]		 0.37 phase 2 inhibitor
bms-690514 fms-like tyrosine kinase 3 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic pain[MeSHID:D059350]		 0.19 phase 2 unknown
bms-690514 fms-like tyrosine kinase 3 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic pain[MeSHID:D059350]		 0.19 phase 2 inhibitor
bms-690514 vascular endothelial growth factor receptor 2 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic pain[MeSHID:D059350]		 0.33 phase 2 inhibitor
bms-690514 vascular endothelial growth factor receptor 2 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic pain[MeSHID:D059350]		 0.33 phase 2 unknown
click here to return to the previous page